Biaryl ether sulfonamides and their use as therapeutic agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9365578
APP PUB NO 20140256736A1
SERIAL NO

14355549

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention is directed to biaryl ether sulfonamides, or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • XENON PHARMACEUTICALS INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chahal, Navjot Burnaby, CA 6 97
Focken, Thilo Burnaby, CA 33 318
Fonarev, Julia Burnaby, CA 12 80
Liu, Shifeng Burnaby, CA 58 760
Oballa, Renata Marcella Burnaby, CA 13 75
Zhang, Zaihui Burnaby, CA 67 611

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 14, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00